Crossmark

Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-018-2784-3

Published Online: 2018-07-31

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hill, Janet http://orcid.org/0000-0002-2866-4859
Magill, Paul

Dorman, Alastair

Hogg, Rosemary

Eggleton, Andrew

Benson, Gary

McFarland, Margaret

Murphy, Lynn

Gardner, Evie

Bryce, Leeann

Martin, Una

Adams, Catherine

Bell, Jennifer

Campbell, Christina

Agus, Ashley

Phair, Glenn

Molloy, Dennis

Mockford, Brian

O’Hagan, Seamus

Beverland, David
Funding

Funding for this research was provided by:

Belfast Arthroplasty Research Trust (20160429/RES001)

Public Health Agency (COM/5242/15)
License Information

Text and Data Mining valid from 2018-07-31
More Information

Article History

Received: 30 March 2018

Accepted: 4 July 2018

First Online: 31 July 2018

Ethics approval and consent to participate

: Ethical approval was granted for this clinical trial by East of England – Cambridge East Research Ethics Committee (16/EE/0068). Clinical trial authorisation has been granted by the MHRA ( 32485/0030/001–0001). All participants gave written informed consent.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below